Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00770250 |
To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
Condition |
---|
Asthma |
Study Type: | Observational |
Study Design: | Cohort, Cross-Sectional |
Official Title: | A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine |
Estimated Enrollment: | 2000 |
Study Start Date: | October 2008 |
Estimated Study Completion Date: | January 2009 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
The first 2 consecutive patients seen during the GP's visit with a diagnosis of persistent asthma
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca France Clinical Study Information | 01 41 29 40 00 | stephan.becouarn@astrazeneca.com |
Study Director: | Alain Castaigne | AstraZeneca |
Responsible Party: | AstraZeneca Pharmaceuticals ( Alain Castaigne, Medical Director ) |
Study ID Numbers: | NIS-RFR-DUM-2008/1 |
Study First Received: | October 7, 2008 |
Last Updated: | October 8, 2008 |
ClinicalTrials.gov Identifier: | NCT00770250 |
Health Authority: | France: French Data Protection Authority |
asthma symptoms words used by patients and physicians express asthma symptoms |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases |
Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |
Immune System Diseases Bronchial Diseases |